Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.1, 2002-01, pp. : 135-137
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Novel cyclic N-hydroxamic acid inhibitors of TNF- synthesis and MMP-13
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. :
Access to resources
Recommend
Novel N-hydroxamic acid hydrazide inhibitors of TNF- synthesis
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 10, 2000-10 ,pp. :
Inhibitors of the production of s-CD23 and the secretion of TNF
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 5, 1998-06 ,pp. :
Hydroxamic Acids Designed as Inhibitors of Urease
Letters in Drug Design & Discovery, Vol. 6, Iss. 3, 2009-04 ,pp. :
Arylsulphonamide hydroxamic acids as potent inhibitors of MMP-13
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 9, 1999-09 ,pp. :